Jian Wei Ni

YM872, a novel selective alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor antagonist, reduces brain damage after permanent focal cerebral ischemia in cats.

M Takahashi, Jian Wei Ni, Sachiko Kawasaki‐Yatsugi et al. · PubMed · 1998 · 48 citations

Receptor Antagonist, Pharmacotherapy, Focal Cerebral Ischemia +20

Neuroprotective efficacy of YM872, an alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor antagonist, after permanent middle cerebral artery occlusion in rats.

Masayasu Takahashi, Jian Wei Ni, Sachiko Kawasaki‐Yatsugi et al. · PubMed · 1998 · 33 citations

Pharmacotherapy, Single Ym872-administration, Cerebral Vascular Regulation +18

YM872, a Novel Selective α-Amino-3-hydroxy-5-methylisoxazole-4-propionic Acid Receptor Antagonist, Reduces Brain Damage after Permanent Focal Cerebral Ischemia in Cats

Masayasu Takahashi, Jian Wei Ni, Sachiko Kawasaki‐Yatsugi et al. · Journal of Pharmacology and Experimental Therapeutics · 1998 · 28 citations

Neuroprotective Efficacy of YM872, an α-Amino-3-Hydroxy-5-Methylisoxazole-4-Propionic Acid Receptor Antagonist, after Permanent Middle Cerebral Artery Occlusion in Rats

Masayasu Takahashi, Jian Wei Ni, Sachiko Kawasaki‐Yatsugi et al. · Journal of Pharmacology and Experimental Therapeutics · 1998 · 16 citations

Effects of YM872 on atrophy of substantia nigra reticulata after focal ischemia in rats

Jian Wei Ni, Masayasu Takahashi, Shin‐ichi Yatsugi et al. · Neuroreport · 1998 · 15 citations

Mca Occlusion, Oxidative Stress, Cerebral Vascular Regulation +24